Top

Published in:

Open Access 01-12-2021 | Mood Disorders | Research

Health-related quality of life (HRQoL) in a population at risk of type 2 diabetes: a cross-sectional study in two Latin American cities

Authors: Luis A. Anillo Arrieta, Tania Acosta Vergara, Rafael Tuesca, Sandra Rodríguez Acosta, Karen C. Flórez Lozano, Pablo Aschner, Rafael Gabriel, Sandra De La Rosa, Julieth P. Nieto Castillo, Noël C. Barengo

Published in: Health and Quality of Life Outcomes | Issue 1/2021

Abstract

Purpose

The purpose of this study was to describe the health-related quality of life (HRQoL) characteristics in a population at risk of developing type 2 diabetes in Barranquilla and Bogotá, Colombia.

Methods

A cross-sectional study with 1135 participants older than 30 years-of-age recruited in Bogotá D.C., and Barranquilla by cluster sampling in 2018 to 2019. The Finnish Diabetes Risk Score (FINDRISC) was used to detect participants at risk of developing type 2 diabetes (T2D). HRQoL was assessed using the EQ-5D-3L questionnaire. Unadjusted and adjusted logistic regression models were used to calculate odds ratios (OR) and their corresponding 95% confidence intervals CI).

Results

Moderate or extreme problems appeared more frequently in the dimensions of Pain/Discomfort (60.8%) and Anxiety/Depression (30.8%). The mean score of the EQ-VAS was 74.3 (± 17.3), significantly larger in the state of complete health (11111) compared with those with problems in more than one of the quality-of-life dimensions. Being female and living in Bogota D.C., were associated with greater odds of reporting problems in the Pain (OR 1.6; 95% CI 1.2–2.2) and Discomfort dimensions (OR 1.6; 95% CI 1.2–2.0) respectively and Anxiety/Depression (OR 1.9; 95% CI 1.3–2.7), (OR 9.1; 95% CI 6.6–12.4), respectively.

Conclusions

As living place and sex were associated with dimensions of Pain/Discomfort and Anxiety/Depression in the HRQoL in people at risk of T2D, greater attention should be paid to these determinants of HRQoL to design and reorient strategies with a territorial and gender perspective to achieve better health outcomes.

Plain English summary

Diabetes is one of the four non-communicable diseases with increasing prevalence in the world, which has made it a serious public health problem. In Colombia, in 2019 diabetes affected 8.4% of the Colombian adult population and more than one million Colombian adults of this age group have hidden or undetected diabetes. This disease is not only characterized by increased premature mortality, loss of productivity, and economic impact, but it also involves a deterioration in the quality of life of people with diabetes with their respective families. However, very Little is known about health-related quality of life (HRQoL) in a population at risk or with prediabetes. This study has evaluated the quality of life in patients at risk of diabetes and their behavior with some variables as sociodemographic, lifestyle, history, and established their difference in two territories of the Colombian Caribbean. The results of this study indicate that the HRQoL of people at risk of type 2 diabetes is affected by factors such as gender, city, dysglycemia, medication for hypertension and education level. Therefore, greater attention should be paid to these determinants of HRQL to design and implement strategies that reduce this risk of developing type 2 diabetes, prevent prediabetes and improve the quality of life in prediabetic or diabetic patients.

Noncommunicable diseases. Global Action Plan for the Prevention and Control of NCDs 2013–2020. Who.int. World Health Organization; 2013 [cited 3 June 2021]. http://www.who.int/nmh/events/ncd_action_plan/en/.

IDF Diabetes Atlas 9th edition 2019. Diabetesatlas.org. [cited 3 June 2021]. https://www.diabetesatlas.org.

Cefalu WT, Buse JB, Tuomilehto J, Fleming GA, Ferrannini E, Gerstein HC, et al. Update and next steps for real-world translation of interventions for type 2 diabetes prevention: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2016;39(7):1186–201. https://doi.org/10.2337/dc16-0873.CrossRefPubMedPubMedCentral

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50. https://doi.org/10.1056/NEJM200105033441801.CrossRefPubMed

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://doi.org/10.1056/NEJMoa012512.CrossRefPubMed

Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–31. https://doi.org/10.2337/diacare.26.3.725.CrossRefPubMed

Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2(2):67–72. https://doi.org/10.3132/dvdr.2005.011.CrossRefPubMed

Franciosi M, De Berardis G, Rossi MCE, Sacco M, Belfiglio M, Pellegrini F, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care. 2005;28(5):1187–94. https://doi.org/10.2337/diacare.28.5.1187.CrossRefPubMed

Gomez-Arbelaez D, Alvarado-Jurado L, Ayala-Castillo M, Forero-Naranjo L, Camacho PA, Lopez-Jaramillo P. Evaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: a longitudinal observational study. World J Diabetes. 2015;6(17):1337–44. https://doi.org/10.4239/wjd.v6.i17.1337.CrossRefPubMedPubMedCentral

10.

Clouet F, Excler-Cavailher G, Christophe B, Masson F, Fasquel D. Type 2 diabetes and short form 36-items Health Survey. Diabetes Metab. 2001;27(6):711–7.PubMed

11.

Redekop WK, Koopmanschap MA, Stolk RP, Rutten GEHM, Wolffenbuttel BHR, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25(3):458–63. https://doi.org/10.2337/diacare.25.3.458.CrossRefPubMed

12.

Schunk M, Reitmeir P, Schipf S, Völzke H, Meisinger C, Thorand B, et al. Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany: health-related quality of life in subjects with and without Type 2 diabetes. Diabetes Med. 2012;29(5):646–53. https://doi.org/10.1111/j.1464-5491.2011.03465.x.CrossRef

13.

Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8(4):120–9. https://doi.org/10.4239/wjd.v8.i4.120.CrossRefPubMedPubMedCentral

14.

Abedini MR, Bijari B, Miri Z, Shakhs Emampour F, Abbasi A. The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand. Health Qual Life Outcomes. 2020;18(1):18. https://doi.org/10.1186/s12955-020-1277-8.CrossRefPubMedPubMedCentral

15.

Chittleborough CR, Baldock KL, Taylor AW, Phillips PJ, North West Adelaide Health Study Team. Health status assessed by the SF-36 along the diabetes continuum in an Australian population. Qual Life Res. 2006;15(4):687–94. https://doi.org/10.1007/s11136-005-3570-8.CrossRefPubMed

16.

Seppälä T, Saxen U, Kautiainen H, Järvenpää S, Korhonen PE. Impaired glucose metabolism and health related quality of life. Prim Care Diabetes. 2013;7(3):223–7. https://doi.org/10.1016/j.pcd.2013.03.001.CrossRefPubMed

17.

Hunger M, Holle R, Meisinger C, Rathmann W, Peters A, Schunk M. Longitudinal changes in health-related quality of life in normal glucose tolerance, prediabetes and type 2 diabetes: results from the KORA S4/F4 cohort study. Qual Life Res. 2014;23(9):2515–20. https://doi.org/10.1007/s11136-014-0689-5.CrossRefPubMed

18.

Neumann A, Schoffer O, Norström F, Norberg M, Klug SJ, Lindholm L. Health-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten Sweden. Health Qual Life Outcomes. 2014;12(1):150. https://doi.org/10.1186/s12955-014-0150-z.CrossRefPubMedPubMedCentral

19.

Makrilakis K, Liatis S, Tsiakou A, Stathi C, Papachristoforou E, Perrea D, et al. Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study. BMC Endocr Disord. 2018;18(1):1–10. https://doi.org/10.1186/s12902-018-0261-3.CrossRef

20.

EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy (Amst, Neth). 1990;16(3):199–208. https://doi.org/10.1016/0168-8510(90)90421-9.CrossRef

21.

Herdman M, Badia X, Berra S. El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria. Aten Primaria. 2001;28(6):425–9. https://doi.org/10.1016/S0212-6567(01)70406-4.CrossRefPubMedPubMedCentral

22.

EQ-5D-3L—EQ-5D. Euroqol.org. [cited 3 June 2021]. https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/.

23.

Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108. https://doi.org/10.1097/00005650-199711000-00002.CrossRefPubMed

24.

Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203–20. https://doi.org/10.1097/00005650-200503000-00003.CrossRefPubMed

25.

McHorney CA, Ware JE Jr, Rachel Lu JF, Sherbourne CD. The MOS 36-ltem short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40–66. https://doi.org/10.1097/00005650-199401000-00004.CrossRefPubMed

26.

Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):54. https://doi.org/10.1186/1477-7525-1-54.CrossRefPubMedPubMedCentral

27.

Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13(12):1203–10. https://doi.org/10.1002/hec.901.CrossRefPubMed

28.

NICE [National Institute for Health and Care Excellence]. Guide to the methods of technology appraisal. (2013, April 2004) . [cited 3 June 2021]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/191504/NICE_guide_to_the_methods_of_technology_appraisal.pdf.

29.

Methods for the economic evaluation of health care programmes—research database, the University of York. York.ac.uk. [cited 3 June 2021]. https://pure.york.ac.uk/portal/en/publications/methods-for-the-economic-evaluation-of-.health-care-programmes(8f69bcee-cdac-44fa-871c-f821470df60a)/export.html

30.

DANE. Proyecciones de Población 2018–2020 Total municipal por área. Retrieved 30 June 2020.

31.

Acosta T, Tuesca R, Florez K, Barengo NC, Anillo L, Flórez-García V, Acosta J, Carvajal L, de la Rosa S, Pachón MJ, Aschner P. Factors associated with low physical activity in two latin american populations at risk of developing type 2 diabetes: an exploratory analysis. Front Public Health. 2021;8:1035. https://doi.org/10.3389/fpubh.2020.589484.CrossRef

32.

Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 2011;37(2):144–51. https://doi.org/10.1016/j.diabet.2010.09.006.CrossRefPubMed

33.

Aschner P, Nieto-Martínez R, Marin A, Ríos M. Validation of the FINDRISK score as a screening tool for people with impaired glucose regulation in Latin America using modified score points for waist circumference according to the validate regional cutoff values for abdominal obesity. Minerva Endocrinol. 2012;37.

34.

Pardini R, Matsudo S. Validation of the International Physical Activity Questionnaire (IPAQ version 6): pilot study in Brazilian young adults. Rev Bras Cien Exerc. 2001;9:45–51.

35.

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95. https://doi.org/10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed

36.

Brown WJ, Trost SG, Bauman A, Mummery K, Owen N. Test–retest reliability of four physical activity measures used in population surveys. J Sci Med Sport. 2004;7(2):205–15. https://doi.org/10.1016/S1440-2440(04)80010-0.CrossRefPubMed

37.

Ekelund U, Sepp H, Brage S, Becker W, Jakes R, Hennings M, et al. Criterion-related validity of the last 7-day, short form of the International Physical Activity Questionnaire in Swedish adults. Public Health Nutr. 2006;9(2):258–65. https://doi.org/10.1079/PHN2005840.CrossRefPubMed

38.

World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.

39.

World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. 2006. Accessed 20 May 2020. https://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/.

40.

WHO | Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. 2013 [cited 3 June 2021]. https://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/.

41.

Rojas-Reyes MX, Gomez-Restrepo C, Rodríguez VA, Dennis-Verano R, Kind P. Calidad de vida relacionada con salud en la población Colombiana: ¿cómo valoran los colombianos su estado de salud? Rev Salud Publica (Bogota). 2017;9(3):340–6. https://doi.org/10.15446/rsap.v19n3.54226.CrossRef

42.

Tapp RJ, Dunstan DW, Phillips P, Tonkin A, Zimmet PZ, Shaw JE, et al. Association between impaired glucose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study. Diabetes Res Clin Pract. 2006;74(2):154–61. https://doi.org/10.1016/j.diabres.2006.03.012.CrossRefPubMed

43.

Väätäinen S, Keinänen-Kiukaanniemi S, Saramies J, Uusitalo H, Tuomilehto J, Martikainen J. Quality of life along the diabetes continuum: a cross-sectional view of health-related quality of life and general health status in middle-aged and older Finns. Qual Life Res. 2014;23(7):1935–44. https://doi.org/10.1007/s11136-014-0638-3.CrossRefPubMed

44.

Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H, et al. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health. 2006;9(1):47–53. https://doi.org/10.1111/j.1524-4733.2006.00080.x.CrossRefPubMed

45.

Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010;8(1):18. https://doi.org/10.1186/1477-7525-8-18.CrossRefPubMedPubMedCentral

46.

Javanbakht M, Abolhasani F, Mashayekhi A, Baradaran HR, Jahangiri noudeh Y. Health related quality of life in patients with type 2 diabetes mellitus in Iran: a national survey. PLoS ONE. 2012;7(8):e44526. https://doi.org/10.1371/journal.pone.0044526.CrossRefPubMedPubMedCentral

47.

Sholihat NK, Utami VV. Health-related quality of life among patients undergoing chronic disease management: a cross-sectional study. J Appl Pharm Sci. 2020;10(3):75–9.CrossRef

48.

Adriaanse MC, Dekker JM, Heine RJ, Snoek FJ, Beekman AJ, Stehouwer CD, et al. Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study. Diabet Med. 2008;25(7):843–9. https://doi.org/10.1111/j.1464-5491.2008.02464.x.CrossRefPubMed

49.

Grandy S, Chapman RH, Fox KM, SHIELD Study Group. Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD): HRQoL with or at risk for type 2 diabetes. Int J Clin Pract. 2008;62(4):562–8. https://doi.org/10.1111/j.1742-1241.2008.01703.x.CrossRefPubMed

50.

Chaparro F, Ortiz F, Bruges M, Cuervo N, Bustamante D. Formulation of a knowledge region city strategy for Bogotá. A proposal for action. Bogotá: Universidad del Rosario - District Planning Administrative Department (DAPD). 2006; 16734481. (s. f.). https://issuu.com/publicacionesfaciso/docs/revista_estudios_sociales__n_49.

51.

Durán RAV, Palacio LMA, Sañudo JEP, Solano MR. Human development and quality of life integrated in an Urban Management Model for Barranquilla. 2009. https://www.academia.edu/3363982/El_desarrollo_humano_y_la_calidad_de_vida_integrados_en_un_Modelo_de_Gesti%C3%B3n_Urbana_para_Barranquilla_Colombia_Human_development_and_quality_of_life_integrated_in_an_urban_management_model_for_Barranquilla_Colombia_.

52.

Lee WJ, Song K-H, Noh JH, Choi YJ, Jo M-W. Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes. J Korean Med Sci. 2012;27(3):255–60. https://doi.org/10.3346/jkms.2012.27.3.255.CrossRefPubMedPubMedCentral

53.

Ruiz MA, Pardo A. Calidad de vida relacionada con la salud: definición y utilización en la práctica médica. Pharmacoecon Span Res Artic. 2005;2:31–43. https://doi.org/10.1007/BF03320897.CrossRef

54.

Urzúa MA, Chirino A, Valladares G. Health related quality of life among patients with type 2 diabetes mellitus. Rev Méd Chile. 2011;139(3):313–20. https://doi.org/10.4067/S0034-98872011000300005.CrossRef

55.

IETS [Instituto de Evaluación Tecnológica en Salud]. Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. 2014.

Title: Health-related quality of life (HRQoL) in a population at risk of type 2 diabetes: a cross-sectional study in two Latin American cities
Authors: Luis A. Anillo Arrieta
Tania Acosta Vergara
Rafael Tuesca
Sandra Rodríguez Acosta
Karen C. Flórez Lozano
Pablo Aschner
Rafael Gabriel
Sandra De La Rosa
Julieth P. Nieto Castillo
Noël C. Barengo
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Mood Disorders
Affective Disorder
Prediabetes
Anxiety
Type 2 Diabetes
Published in: Health and Quality of Life Outcomes / Issue 1/2021
Electronic ISSN: 1477-7525
DOI: https://doi.org/10.1186/s12955-021-01894-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Health-related quality of life (HRQoL) in a population at risk of type 2 diabetes: a cross-sectional study in two Latin American cities

Abstract

Purpose

Methods

Results

Conclusions

Plain English summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Plain English summary

Please log in to get access to this content

Other articles of this Issue 1/2021

Assessment of the health utility of patients with leukemia in China

Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member

Confirmatory and bi-factor analysis of the Short Form Health Survey 8 (SF-8) scale structure in a German general population sample

Health-related quality of life and social constraints among Chinese breast cancer patients: a cross-sectional study

Measuring self-reported ability to perform activities of daily living: a Rasch analysis

The analysis of fertility quality of life and the influencing factors of patients with repeated implantation failure